UAB Research: Half of HIV-Exposed Babies in Parts of Africa Not Receiving Available HIV Prevention Drug

Published July 19, 2010 at 9:17 a.m.
In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African countries received a minimal dose of the prevention drug nevirapine, say researchers at the University of Alabama at Birmingham.


Back | Read more at University of Alabama News